InvestorsObserver
×
News Home

Will 180 Life Sciences Corp (ATNF) Stay at the Bottom of the Healthcare Sector?

Friday, March 22, 2024 02:17 PM | InvestorsObserver Analysts

Mentioned in this article

Will 180 Life Sciences Corp (ATNF) Stay at the Bottom of the Healthcare Sector?

180 Life Sciences Corp (ATNF) is near the bottom in its sector according to InvestorsObserver. ATNF gets an overall rating of 7. That means it scores higher than 7% of stocks. 180 Life Sciences Corp gets a 8 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

Overall Score - 7
ATNF has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on ATNF!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 7 would rank higher than 7 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With 180 Life Sciences Corp Stock Today?

180 Life Sciences Corp (ATNF) stock is down -20.4% while the S&P 500 has risen 0.02% as of 1:36 PM on Friday, Mar 22. ATNF is down -$0.71 from the previous closing price of $3.48 on volume of 306,355 shares. Over the past year the S&P 500 has risen 32.76% while ATNF is down -92.41%. ATNF lost -$247.21 per share the over the last 12 months. Click Here to get the full Stock Report for 180 Life Sciences Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App